Lucknow

Knocksense Shorts | CDRI develops first-of-its-kind oral pill to fasten bone healing process

CDRI-1500, the orally active fracture healing synthetic molecule, can significantly help in fracture healing.

Khushbu Kirti

Lucknow's Central Drug Research Institute (CDRI) has come out with an oral pill that might help fasten the process of healing after a fracture. The institution is currently working on two bone healing entities, namely CDRI-1500 and CDRI-399. Necessary approvals from drug regulatory bodies have been received and the phase-1 clinical trials for CDRI-1500 will begin soon.

Tests show that the drug has therapeutic potential and can work as a rapid fracture repairing agent. It can also help improve bone health in the management of osteoporosis and other bone-related disorders.  

"Pharmacological data suggests that S007-1500 possesses potential osteogenic property and shows accelerated fracture repairing by significantly increasing the callus formation at the fracture site in the test models," CDRI wrote.

CDRI-1500 is being said to be safe, economical and the first-of-its-kind.

To get all the latest content, download our mobile application. Available for both iOS & Android devices. 

Kanpur's winter bucket list: 11 things to do before the season slips away

Ahmedabad’s Sabarmati Riverfront Phase-2 sees 83% progress, December 2027 deadline set

Rakul Preet Singh & Jackky Bhagnani bring Canadian coffee brand Blenz Coffee to Mumbai

The city never sleeps & neither do these 7 late-night eateries in Mumbai

Clock it, Lucknow! 9 towers that have been keeping time for years

SCROLL FOR NEXT